Cargando…
KRAS突变的非小细胞肺癌的研究进展
Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for 80%-85% of all patients with lung cancer, the majority of patients with lung cancer at the time of diagnosis is in the advanced stage. The development of target therapy based on has c...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999922/ https://www.ncbi.nlm.nih.gov/pubmed/29764594 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.05.11 |